Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 Earnings Call Transcript February 12, 2026 Aethlon Medical, Inc. misses on earnings expectations. Reported EPS is $-2.45 EPS, expectations were $-2.01.
Basalt fiber-reinforced laminate using promising bio-based vitrimer formulations meets wind industry standards.
IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results